Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors
Zeev Bronfeld, the current Chairman of the Company's Board of Directors, will retire on the same day.
- Zeev Bronfeld, the current Chairman of the Company's Board of Directors, will retire on the same day.
- "We are very pleased that Eliot will be joining our Board of Directors," commented Dror Bashan, Protalix's President and Chief Executive Officer.
- He will be a valuable contribution to our Board of Directors as we leverage our development successes to strengthen our research and development efforts."
- "I am delighted and honored to join Protalix as Chairman of its Board of Directors, and very much look forward to working with Protalix's talented officers, directors and employees," said Dr. Forster.